作者
Guoliang Chai,A. Dinsmoor Webb,Chen Li,Danny Antaki,Sang-Moon Lee,Martin W. Breuss,Nhi Lang,Valentina Stanley,Paula Anzenberg,Xiaoxu Yang,Trevor G Marshall,Patrick M. Gaffney,Klaas J. Wierenga,Brian Hon‐Yin Chung,Mandy Ho‐Yin Tsang,Lynn Pais,Alysia Kern Lovgren,Grace E. VanNoy,Heidi L. Rehm,Ghayda Mirzaa,Eyby Leon,Jullianne Diaz,Alexander Neumann,Arnout P. Kalverda,Iain W. Manfield,David Parry,Clare V. Logan,Colin A. Johnson,David T. Bonthron,Elizabeth M. A. Valleley,Mahmoud Y. Issa,Sherif F. Abdel‐Ghafar,Mohamed S. Abdel‐Hamid,Patricia A. Jennings,Maha S. Zaki,Eamonn Sheridan,Joseph G. Gleeson
摘要
Autosomal-recessive cerebellar hypoplasia and ataxia constitute a group of heterogeneous brain disorders caused by disruption of several fundamental cellular processes. Here, we identified 10 families showing a neurodegenerative condition involving pontocerebellar hypoplasia with microcephaly (PCHM). Patients harbored biallelic mutations in genes encoding the spliceosome components Peptidyl-Prolyl Isomerase Like-1 (PPIL1) or Pre-RNA Processing-17 (PRP17). Mouse knockouts of either gene were lethal in early embryogenesis, whereas PPIL1 patient mutation knockin mice showed neuron-specific apoptosis. Loss of either protein affected splicing integrity, predominantly affecting short and high GC-content introns and genes involved in brain disorders. PPIL1 and PRP17 form an active isomerase-substrate interaction, but we found that isomerase activity is not critical for function. Thus, we establish disrupted splicing integrity and “major spliceosome-opathies” as a new mechanism underlying PCHM and neurodegeneration and uncover a non-enzymatic function of a spliceosomal proline isomerase.